A faecal microbiota transplant (FMT) is the introduction of microbiome material from a healthy donor into a patient.
Currently, FMTs are used to treat patients suffering from Clostridioides difficile infection (CDI), a type of bacterial infection that causes severe diarrhoea and potentially life-threatening complications.
But the potential of FMTs is not limited to curing C. difficile infections. Researchers globally are exploring FMTs for a variety of other indications such as Inflammatory Bowel Disease (IBD) and Autism.
Locally, AMILI has been studying the use of FMTs for IBD, in addition to a number of other conditions.
A pioneer of FMTs in SEA, AMILI set up SEA’s first stool bank for FMTs in early 2020. Since then, we have provided FMT preparations to a number of hospitals and clinics in the region.